Thermo Fisher Scientific Reports First Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Thermo Fisher Scientific (TMO) Tops Q1 EPS by 8c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus
April 24, 2019 6:05 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $2.81, $0.08 better than the analyst estimate of $2.73. Revenue for the quarter came in at $6.12 billion versus the consensus estimate of $6.02 billion.
First quarter revenue increased to $6.12 billion.First quarter GAAP diluted earnings per share (EPS) increased 41% to $2.02.First quarter adjusted EPS increased 12% to $2.81.Launched a range of new products, including two Thermo Scientific instruments for materials analysis the Nicolet Summit FTIR spectrometer and the Helios 5 DualBeam scanning electron microscope and in specialty diagnostics, received FDA clearance for a new ImmunoCAP... More